Prognostic score summary
| Category . | DIPSS, N (%) . | DIPSS Plus, N (%) . | MIPSS70+, N (%) . | GPSS, N (%) . | Comorbidity, N (%) . |
|---|---|---|---|---|---|
| Very high | — | — | 8 (7) | — | — |
| High | 10 (5) | 26 (13) | 47 (42) | 30 (21) | 47 (24) |
| Intermediate-2 | 79 (41 | 82 (42) | — | 62 (44) | 41 (21) |
| Intermediate-1 | 71 (37%) | 57 (30) | — | 38 (27) | 71 (37) |
| Intermediate | — | — | 19 (17) | — | — |
| Low | 33 (17) | 28 (15) | 39 (35) | 10 (7) | 34 (18) |
| No. evaluated | 193 | 193 | 113 | 140 | 193 |
| No. excluded | 0 | 0 | 80∗ | 53∗∗ | 0 |
| Total | 193 | 193 | 193 | 193 | 193 |
| Category . | DIPSS, N (%) . | DIPSS Plus, N (%) . | MIPSS70+, N (%) . | GPSS, N (%) . | Comorbidity, N (%) . |
|---|---|---|---|---|---|
| Very high | — | — | 8 (7) | — | — |
| High | 10 (5) | 26 (13) | 47 (42) | 30 (21) | 47 (24) |
| Intermediate-2 | 79 (41 | 82 (42) | — | 62 (44) | 41 (21) |
| Intermediate-1 | 71 (37%) | 57 (30) | — | 38 (27) | 71 (37) |
| Intermediate | — | — | 19 (17) | — | — |
| Low | 33 (17) | 28 (15) | 39 (35) | 10 (7) | 34 (18) |
| No. evaluated | 193 | 193 | 113 | 140 | 193 |
| No. excluded | 0 | 0 | 80∗ | 53∗∗ | 0 |
| Total | 193 | 193 | 193 | 193 | 193 |
Total patients (N = 193) were evaluated for their respective DIPSS, DIPSS Plus, MIPSS70+, GPSS, and comorbidity risk scores. This table summarizes the heterogeneity of calculated risk among different risk scores.